Not only can consumers handle their personal genetic information, but they are getting genomically oriented and anchored about such data.

The problem is that it takes physicians so long to accept a radical change. And the lag is unacceptable.

Of course, the medical profession doesn't like D.I.Y. anything.

For people who have heart disease, statins are great. But if all you've had is high cholesterol, what you're doing is taking this 1/100 chance of getting a benefit and offsetting it with 1/200 chance of getting diabetes.

Warfarin is the drug the medical community loves to hate.

I have had my genome fully sequenced and have learned a great deal about which medications I would respond to and which might or would induce major side effects, along with knowing many medical conditions for which I'm particularly susceptible.

The digital world has been in a separate orbit from our medical cocoon, and it's time the boundaries be taken down.